精确化学放射疗法通过EGFR向放射治疗激活药物联合体
Shanmeng Lin1,2, Jinyan Luo1, Jinying Yang3
1Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055 Guangdong, China.
Journal of medicinal chemistry
|October 23, 2025
概括
这项研究引入了放射治疗触发的抗体-药物合物 (RT-ADCs),这些合物向表达EGFR的瘤. 在暴露于X射线时,RT-ADCs释放细胞毒剂,导致显著的瘤回归和延长小鼠的存活时间.
科学领域:
- 在瘤学瘤学.
- 放射疗法是一种放射治疗.
- 药物运输 药物运输 药物运输
背景情况:
- 同时化疗放射治疗 (CCRT) 结合化疗和放射治疗以提高疗效.
- CCRT的局限性包括全身毒性和低于最佳的药物输送.
- 需要有针对性的药物输送系统来提高深层瘤的治疗结果.
研究的目的:
- 开发和评估用于向癌症治疗的放射治疗触发的抗体-药物合物 (RT-ADCs).
- 为了利用X射线辐射,在瘤部位局部释放药物.
- 在针对EGFR表达瘤的临床前模型中评估RT-ADC的疗效.
主要方法:
- RT-ADCs的设计包括一个对X射线敏感的阿佐烯链接剂和一个向EGFR的抗体.
- 在瘤部位RT-ADC积累的体外和体内评估.
- 评估X射线诱导的阿佐链体裂变和随后的细胞毒剂释放.
- 在小鼠模型中评估瘤生长抑制 (TGI) 和中位生存时间 (MST).
主要成果:
- RT-ADCs证明了精确准表达EGFR的瘤细胞.
- 通过X射线照射,通过阿佐链体裂变触发了细胞毒性剂的局部释放.
- 在体内研究显示,瘤几乎完全根除,TGI超过90%.
- 在RT-ADC治疗组中,中位生存时间显著延长.
结论:
- RT-ADCs代表了针对性癌症治疗的有希望的策略,特别是针对深层瘤.
- 放射治疗触发的药物释放机制提高了治疗疗效,并最大限度地降低了全身毒性.
- RT-ADC技术具有在瘤学中临床应用的巨大潜力.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
574
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
574